SRE — Sempra

Wall Street is positive on the story: the analyst consensus is Buy, with 21 buy/strong-buy ratings and 5 holds, and the average 12-month target is $105.33 versus the $84.73 price. Q2 2026 adjusted EPS of $1.16 beat the $1.01 consensus. But the tape does not confirm that enthusiasm: as of 2026-08-27, RSI stood at 42.7, the stock was below its 20/50/200-day moving averages, and utilities remain sensitive to interest-rate headlines. That combination of bullish fundamentals and weak price momentum makes the current market sentiment neutral.

Revenue has been basically flat, not compounding: Q2 2026 revenue of $2.997B was essentially unchanged from Q2 2025, and Q1 2026 was down 3.8% year over year. The real story is an earnings inflection. GAAP net income was whipsawed by below-the-line items in Q3-Q4 2025—operating income was solid at $627M and $1.105B, but net income dropped to $95M and $352M respectively—then rebounded sharply in Q1-Q2 2026 to $1.037B and $797M. Q2 2026 EPS came in at $1.21 versus $0.71 a year earlier, and operating margins improved to roughly 28-30% in 2026 from about 19-20% in the comparable 2025 quarters. This is a V-shaped earnings normalization after a one-off-hit 2025, not a smooth acceleration.

At the 2026-08-27 price of $84.73, the headline trailing P/E of 24.4x is misleading because trailing EPS of $3.49 includes the impaired 2025 quarters. On forward adjusted earnings, the stock is much cheaper: about 16.8x the midpoint of 2026 adjusted EPS guidance ($5.05) and about 15.7x the 2027 guidance midpoint ($5.40). That is well below Sempra's 5-year average P/E of 24.7x, though that average was set in a lower-rate era. Price-to-sales of 4.1x is above the 5-year average of 3.55x, but that is a less meaningful metric for regulated utilities. The PEG ratio is negative and not useful here due to one-time charges. Overall, SRE looks fairly valued to modestly attractive on normalized forward earnings—not expensive.

At the 2026-08-27 price of $84.73, the market is pricing SRE as a slow-growth utility with heavy capex and financing risk rather than pricing in the earnings growth management has guided to. The stock trades at roughly 15.7-16.8x forward adjusted EPS, while the analyst consensus target implies a 19-20x forward multiple. If SRE delivers the 2027 midpoint of $5.40 and the multiple simply normalizes to 18x, the stock is worth about $97; at 19-20x, it is worth $103-108. The bear case is that negative free cash flow, LNG execution hiccups, or California regulatory issues force guidance lower, keeping the multiple pinned in the mid-teens. The playbook: watch quarterly adjusted EPS and capital-allocation updates—clean prints should close the gap to analyst targets.

Technicals are weak but not oversold. As of 2026-08-27, RSI was 42.7, below the 50 midpoint but above the 30 oversold threshold. Price was 1.0% below its 20-day moving average, 5.6% below its 50-day, and 7.2% below its 200-day moving average. The stock is in the lower third of its 52-week range ($78.97 to $101.04), still in a downtrend from the 2026 high. There is no momentum-based entry signal yet; patient buyers could look for a test of the $78.97 low or a reclaim of the 50-day near $89.70.

• Interest rates: utility valuations are highly rate-sensitive, and Sempra's $31.0B long-term debt plus negative free cash flow make its cost of capital and refinancing costs a major swing factor.
• Texas power demand: Oncor is positioned to benefit from data-center load growth, electrification, and transmission buildout, with management targeting more than 60% of 2030 rate base from Texas.
• California regulatory exposure: SoCalGas and SDG&E remain exposed to wildfire costs, litigation, and regulatory friction, though the Texas/LNG pivot is gradually reducing that concentration.
• LNG project execution: ECA LNG Phase 1 and Port Arthur LNG are multiyear, capital-intensive projects with operational and construction risk; the ECA compressor issue already caused a delay.
• Capital recycling and funding: asset sales like the ~$500M Ecogas divestiture and partnership structures help self-fund the capex program, but equity or debt issuance needs remain an overhang.

• Q3 2026 earnings in early November 2026: updates on ECA LNG Phase 1 commercial ramp, Port Arthur LNG progress, and reaffirmation of 2026-2027 adjusted EPS guidance.
• Closing the Ecogas sale and additional capital-recycling deals that reduce external funding needs.
• New Texas transmission projects or rate-base milestones that push 2027 and beyond estimates higher.
• A decline in long-term interest rates, which would likely trigger utility-sector multiple expansion.
• Favorable California regulatory decisions on wildfire cost recovery or rate cases, which could remove a persistent discount.

• Capex execution and project delays: quarterly free cash flow was -$1.57B in Q2 2026 and roughly -$5.9B on a trailing twelve-month basis, so slippage is expensive.
• Financing and interest-rate risk: cash was only $154M at Q2 2026, long-term debt was $31.0B, and the negative free cash flow requires continued access to debt and equity markets.
• California regulatory and wildfire risk: potential cost disallowances, litigation, and rising mitigation expenses could pressure returns.
• Earnings quality: GAAP EPS has been volatile due to below-the-line charges; adjusted EPS could be missed if impairments or one-off gains recur.
• LNG market and gas-price risk: weaker global LNG demand or poor project economics could reduce returns from Sempra Infrastructure.

At $84.73, SRE is a reasonable long-term accumulation candidate rather than a momentum buy. The 2.8% dividend, roughly 16x forward adjusted earnings, and credible 7-9% EPS growth target give it a solid valuation cushion, while Texas transmission and LNG growth are genuine tailwinds. The main reasons not to be more aggressive are the negative free cash flow, stretched balance sheet, and still-weak technical trend. Overall, the risk/reward is skewed positive for a patient holder, but the stock needs execution and/or lower rates to re-rate meaningfully.

I applied an 18x justified forward P/E to the midpoint of 2027 adjusted EPS guidance of $5.40, giving $97.20; this is consistent with applying roughly 19x to the consensus forward EPS estimate of $5.11. The 18-19x multiple is a deliberate discount to SRE's 5-year average P/E of 24.7x and to the analyst consensus target-implied multiple of ~20x, because the higher-rate environment, negative free cash flow, and LNG execution risk warrant a lower multiple even if the 7-9% EPS growth target is credible.